Bgc-20-1531
sodium [4-[[4-(5-methoxy-2-pyridinyl)phenoxy]methyl]-5-methylfuran-2-carbonyl]-(2-methylphenyl)sulfonylazanide
Molecular Identity
Bgc-20-1531
sodium [4-[[4-(5-methoxy-2-pyridinyl)phenoxy]methyl]-5-methylfuran-2-carbonyl]-(2-methylphenyl)sulfonylazanide
PubChem CID: 25209437
2D Structure
Properties
C26H23N2NaO6S
Molecular Formula
514.50
Molecular Weight
g/mol
514.1175
Exact Mass
Da
105
TPSA
Good oral absorption (< 140 A²)
0
H-Bond Donors
8
H-Bond Acceptors
801
Complexity
SMILES
Canonical SMILES
SMILES: CC1=CC=CC=C1S(=O)(=O)[N-]C(=O)C2=CC(=C(O2)C)COC3=CC=C(C=C3)C4=NC=C(C=C4)OC.[Na+]Isomeric SMILES
SMILES: CC1=CC=CC=C1S(=O)(=O)[N-]C(=O)C2=CC(=C(O2)C)COC3=CC=C(C=C3)C4=NC=C(C=C4)OC.[Na+]Synonyms(20)
1186532-61-5BGC-20-1531BGC 20-1531PGN 15319QV7JG4XYZBGC20-1531AP-1531RefChem:1195934-(4-(5-methoxypyridin-2-yl)phenoxymethyl)-5-methyl-N-((2-methylbenzene)sulfonyl)oxolane-2-carboxamideBGC201531sodium (4-((4-(5-methoxypyridin-2-yl)phenoxy)methyl)-5-methylfuran-2-carbonyl)(o-tolylsulfonyl)amideCHEMBL3260771sodium;[4-[[4-(5-methoxypyridin-2-yl)phenoxy]methyl]-5-methylfuran-2-carbonyl]-(2-methylphenyl)sulfonylazanideorb746290orb1219054
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Bgc-20-1531
Loading drug network...